Asensus Surgical Files For FDA Nod For Additional Capabilities Of Laparoscopy System

Asensus Surgical Inc (NYSE:ASXC) has filed a 510(k) submission with the FDA for an expansion of capabilities on the previously cleared Intelligent Surgical Unit (ISU).
The ISU is used on the Company's Senhance Surgical System, which enables digital laparoscopy.
The current features of the ISU enable machine vision-driven control of the camera for a surgeon. The new features would expand to include more advanced features to gather real-time data during surgery based on the anatomical structures in the surgical field.
Price Action: ASXC shares are up 5. 3% at $2.59 during the premarket session on the last check Wednesday.
Related content: Benzinga's Full FDA Calendar.

To add Benzinga News as your preferred source on Google, click here.